Cancer patients and
their families

What is radiation oncology? Here, patients and their families can find a comprehensive guide of radiotherapy treatments in Belgium.

Access

Healthcare Professionals and radiation oncology

As a medical professional, you're familiar with the basics of radiotherapy. Visit the following pages for a more elaborate approach on the topic.

Access

Healthcare Policy makers and radiation oncology

Radiation oncology is not like other medical specialties. This section deals with existing quality initiatives and cost-effectiveness.

Access

Home > Symposium

BRAVO Symposium

BRAVO Symposium 2018 - November 17, 2018

I would like to receive an invitation or Register

bemedtech bravo

Belgian Radiation Oncology Awareness and Visibility Organization

BRAVO Symposium - November 17, 2018

 

 “Fighting Breast Cancer with Innovative Radiotherapy… for everyone?

Venue: SQUARE – Brussels Meeting Centre       Date: 17/11/2018        Cost: free - register

Topic: “Fighting Breast Cancer with Innovative Radiotherapy… for everyone?”

Program:

Moderators: Dr J.-F. Daisne, Prof. Dr W. De Neve, Dr C. Kirkove, Dr V. Remouchamps, Prof. Dr E. Van Limbergen

Note: Accreditation is applied for in category 6 – Ethics and Economy

I would like to receive an invitation

_________________________________________________________________________________________

On the occasion of this symposium, BRAVO developed an expert document about the therapeutic value of modern radiotherapy.


Presentations at BRAVO Symposium 2016 - October 1, 2016

Welcome address

(Steven Cuypers, Co-President BRAVO for the industry)

Radiotherapy in Belgium: An insight through the European looking glass

(Prof Dr. Yolande Lievens, Chair Radiation Oncology Department at University Hospital Ghent)

Modern radiation oncology, a subtle balance between standardisation and individualisation

(Prof. Dr Dirk Verellen – Iridium Kankernetwerk, Antwerp; VUB, Faculteit Geneeskunde en Farmacie)

High quality radiotherapy: a life saver or just a costly exercise?

(Prof. Dr Dirk Van Gestel – Chair Radiation Oncology Department at Institut Jules Bordet, Université Libre de Bruxelles, Brussels)

Expanding Global Access to Radiotherapy: Demand, Supply, and Benefit

(Prof. David Jaffray – Senior Scientist at Princess Margaret Cancer Centre; Executive VP Technology and Innovation at UHN; co-author of “Expanding global access to radiotherapy” in The Lancet (2015))

Closing Remarks

(Prof. Dr Gert De Meerleer – Co-President BRAVO for the physicians; Radiation Oncologist at University Hospital Leuven)